Neutralizing antibodies in patients with chronic hepatitis C, genotype 1, against a panel of genotype 1 culture viruses: lack of correlation to treatment outcome.
The correlation of neutralizing antibodies to treatment outcome in patients with chronic hepatitis C virus (HCV) infection has not been established. The aim of this study was to determine whether neutralizing antibodies could be used as an outcome predictor in patients with chronic HCV, genotype 1,...
Guardado en:
Autores principales: | Jannie Pedersen, Tanja B Jensen, Thomas H R Carlsen, Kristian Schønning, Peer Brehm Christensen, Alex Lund Laursen, Henrik Krarup, Jens Bukh, Nina Weis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/07e65dcbfd714cfdb93daf9844005c81 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
por: Troels K H Scheel, et al.
Publicado: (2012) -
The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.
por: Bimmi Shrestha, et al.
Publicado: (2010) -
Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.
por: S Kyle Austin, et al.
Publicado: (2012) -
Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.
por: Zhen-yong Keck, et al.
Publicado: (2012) -
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.
por: Lars Haukali Omland, et al.
Publicado: (2011)